159 related articles for article (PubMed ID: 28869211)
1. Clinicians' Views on Therapeutic Outcomes of Systemic Interventions and on the Ability of the EQ-5D to Capture these Outcomes.
Schawo SJ; Brouwer WBF; Hakkaart L
J Ment Health Policy Econ; 2017 Sep; 20(3):131-136. PubMed ID: 28869211
[TBL] [Abstract][Full Text] [Related]
2. Does the EQ-5D measure quality of life in schizophrenia?
Halling Hastrup L; Nordentoft M; Hjorthøj C; Gyrd-Hansen D
J Ment Health Policy Econ; 2011 Dec; 14(4):187-96. PubMed ID: 22345360
[TBL] [Abstract][Full Text] [Related]
3. Views of the UK General Public on Important Aspects of Health Not Captured by EQ-5D.
Shah KK; Mulhern B; Longworth L; Janssen MF
Patient; 2017 Dec; 10(6):701-709. PubMed ID: 28409481
[TBL] [Abstract][Full Text] [Related]
4. Presentation and validation of the Abbreviated Self Completion Teen-Addiction Severity Index (ASC T-ASI): A preference-based measure for use in health-economic evaluations.
Reckers-Droog V; Goorden M; Kaminer Y; van Domburgh L; Brouwer W; Hakkaart-van Roijen L
PLoS One; 2020; 15(9):e0238858. PubMed ID: 32915870
[TBL] [Abstract][Full Text] [Related]
5. The search for relevant outcome measures for cost-utility analysis of systemic family interventions in adolescents with substance use disorder and delinquent behavior: a systematic literature review.
Schawo S; Bouwmans C; van der Schee E; Hendriks V; Brouwer W; Hakkaart L
Health Qual Life Outcomes; 2017 Sep; 15(1):179. PubMed ID: 28927410
[TBL] [Abstract][Full Text] [Related]
6. Exploring potential EQ-5D bolt-on dimensions with a qualitative approach: an interview study in Hong Kong SAR, China.
Cheuk Wai Ng C; Wai Ling Cheung A; Lai Yi Wong E
Health Qual Life Outcomes; 2024 May; 22(1):42. PubMed ID: 38816769
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the preference-based EQ-5D-5L and SF-6D in patients with end-stage renal disease (ESRD).
Yang F; Lau T; Lee E; Vathsala A; Chia KS; Luo N
Eur J Health Econ; 2015 Dec; 16(9):1019-26. PubMed ID: 25519850
[TBL] [Abstract][Full Text] [Related]
8. Dutch Tariff for the Five-Level Version of EQ-5D.
M Versteegh M; M Vermeulen K; M A A Evers S; de Wit GA; Prenger R; A Stolk E
Value Health; 2016 Jun; 19(4):343-52. PubMed ID: 27325326
[TBL] [Abstract][Full Text] [Related]
9. Unit Costs of Delinquent Acts for Use in Economic Evaluations.
Reckers-Droog VT; Goorden M; Dijkgraaf MGW; Van Eeren HV; McCollister KE; Hakkaart-van Roijen L
J Ment Health Policy Econ; 2019 Jun; 22(2):71-79. PubMed ID: 31319377
[TBL] [Abstract][Full Text] [Related]
10. How important is health status in defining quality of life for older people? An exploratory study of the views of older South Australians.
Milte CM; Walker R; Luszcz MA; Lancsar E; Kaambwa B; Ratcliffe J
Appl Health Econ Health Policy; 2014 Feb; 12(1):73-84. PubMed ID: 24254996
[TBL] [Abstract][Full Text] [Related]
11. Development of a disease-specific version of the EQ-5D-5L for use in patients suffering from psoriasis: lessons learned from a feasibility study in the UK.
Swinburn P; Lloyd A; Boye KS; Edson-Heredia E; Bowman L; Janssen B
Value Health; 2013 Dec; 16(8):1156-62. PubMed ID: 24326169
[TBL] [Abstract][Full Text] [Related]
12. A comparison of SF-6D and EQ-5D utility scores in a study of patients with schizophrenia.
McCrone P; Patel A; Knapp M; Schene A; Koeter M; Amaddeo F; Ruggeri M; Giessler A; Puschner B; Thornicroft G
J Ment Health Policy Econ; 2009 Mar; 12(1):27-31. PubMed ID: 19346564
[TBL] [Abstract][Full Text] [Related]
13. A Differential Item Functioning Analysis of the EQ-5D in Cancer.
Smith AB; Cocks K; Parry D; Taylor M
Value Health; 2016 Dec; 19(8):1063-1067. PubMed ID: 27987634
[TBL] [Abstract][Full Text] [Related]
14. Does the EQ-5D capture the concerns measured by the Palliative care Outcome Scale? Mapping the Palliative care Outcome Scale onto the EQ-5D using statistical methods.
Dzingina MD; McCrone P; Higginson IJ
Palliat Med; 2017 Sep; 31(8):716-725. PubMed ID: 28434392
[TBL] [Abstract][Full Text] [Related]
15. Comparison of population health status in six european countries: results of a representative survey using the EQ-5D questionnaire.
König HH; Bernert S; Angermeyer MC; Matschinger H; Martinez M; Vilagut G; Haro JM; de Girolamo G; de Graaf R; Kovess V; Alonso J;
Med Care; 2009 Feb; 47(2):255-61. PubMed ID: 19169128
[TBL] [Abstract][Full Text] [Related]
16. The EQ-5D in alcohol dependent patients: relationships among health-related quality of life, psychopathology and social functioning.
Günther O; Roick C; Angermeyer MC; König HH
Drug Alcohol Depend; 2007 Jan; 86(2-3):253-64. PubMed ID: 16930855
[TBL] [Abstract][Full Text] [Related]
17. Measuring the outcomes of long-term care for unpaid carers: comparing the ASCOT-Carer, Carer Experience Scale and EQ-5D-3 L.
Rand S; Malley J; Vadean F; Forder J
Health Qual Life Outcomes; 2019 Dec; 17(1):184. PubMed ID: 31842952
[TBL] [Abstract][Full Text] [Related]
18. Comparing and explaining differences in the magnitude, content, and sensitivity of utilities predicted by the EQ-5D, SF-6D, HUI 3, 15D, QWB, and AQoL-8D multiattribute utility instruments.
Richardson J; Khan MA; Iezzi A; Maxwell A
Med Decis Making; 2015 Apr; 35(3):276-91. PubMed ID: 25159172
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the performance of the EQ-5D and the EQ-5D-Y health-related quality of life instruments in South African children.
Jelsma J
Int J Rehabil Res; 2010 Jun; 33(2):172-7. PubMed ID: 20351650
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
